LEVOLEUCOVORIN CALCIUM (levoleucovorin) by Gland Pharma is high-dose methotrexate therapy levoleucovorin is the pharmacologically active isomer of 5-formyl tetrahydrofolic acid. Approved for pernicious anemia, megaloblastic anemia secondary to lack of vitamin b 12, because of the risk of progression of neurologic manifestations despite hematologic remission and 1 more indications. First approved in 2017.
Drug data last refreshed 18h ago
High-Dose Methotrexate Therapy Levoleucovorin is the pharmacologically active isomer of 5-formyl tetrahydrofolic acid. Levoleucovorin does not require reduction by the enzyme dihydrofolate reductase in order to participate in reactions utilizing folates as a source of "one-carbon" moieties.…
Worked on LEVOLEUCOVORIN CALCIUM at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo